Net Cash Provided by (Used in) Operating Activities |
-292K |
USD |
-39.9% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
287K |
USD |
+24.4% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
-100% |
Q1 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
6.49M |
shares |
-11.5% |
Q1 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-4.8K |
USD |
-122% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
16.8K |
USD |
-88% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
1.22M |
USD |
+60.5% |
Q4 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Gross |
1.22M |
USD |
+60.5% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Interest Expense |
42.2K |
USD |
+240% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |